Orio Therapeutics is developing an innovative technology that modifies therapeutic proteins to improve delivery through controlled localization for increased efficacy and reduced dose. Today, Orio Therapeutics is focused on developing therapies for patients with myocardial infarction. However, it remains capable of modifying any protein-based therapy with its technology